AMGN Amgen
Amgen earnings company data as of 2:06 PM ET 10/30
- 0 of 1 EPS beats
- 3 Owners
- Rank #295
- Max 3.1%
- Master 0.00%
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | 5.69 | — | — |
| Rev | $10.08B | — | — | ||
| FY2026 Q2 | 4 Aug | EPS | 5.60 | 4.37 | Miss -22.0% |
| Rev | — | — | — |
Who owns this now
Largest portfolio weights among holders, up to 3.1% (Torray Investment Partners). Not free-float ownership.
Insider trades
Open-market buys and sales by AMGN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $8.2M sold by 4 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Rachna Khosla SVP, Business DevelopmentSale$1.3M 3,252 shares at $414.05 34% of stakeTraded Aug 11–13 Filed Aug 13
-
Derek Miller SVP, Human ResourcesSale$1.6M 3,890 shares at $402.54 24% of stakeTraded Aug 6 Filed Aug 7
-
Nancy A. Grygiel SVP & CCOSale$1.2M 2,970 shares at $402.16 29% of stakeTraded Aug 6 Filed Aug 7
-
Nancy A. Grygiel SVP & CCOSale$400K 1,237 shares at $323.73 15% of stakeTraded May 4 Filed May 5
-
Nancy A. Grygiel SVP & CCOSale$1.1M 3,139 shares at $337.26 30% of stakeTraded Nov 20, 2025 Filed Nov 21, 2025
-
Rachna Khosla SVP, Business DevelopmentSale$299K 890 shares at $336.24 11% of stakeTraded Nov 12, 2025 Filed Nov 13, 2025
-
Murdo Gordon EVP, Global Commercial OpsSale$2.3M 6,879 shares at $336.83 14% of stakeTraded Nov 12, 2025 Filed Nov 13, 2025
Also filed in the last 12 months, not counted as buying or selling: 54 share withholdings for taxes, 32 stock grants, 7 option exercises, and 2 gifts.
SEC filings
Recent issuer filings from EDGAR, 7 shown.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.